File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Health and doping in elite-level cycling

TitleHealth and doping in elite-level cycling
Authors
KeywordsAmateur Level
Cycling
Doping Behaviors
Health Risks
Performance-Enhancing Drugs
Professional Level
Sport
Issue Date2012
PublisherBlackwell Munksgaard. The Journal's web site is located at http://www.blackwellpublishing.com/journals/SMS
Citation
Scandinavian Journal Of Medicine And Science In Sports, 2012, v. 22 n. 5, p. 596-606 How to Cite?
AbstractThe protection of the health of athletes is one of the three criteria taken into account when registering a substance in the World Anti-Doping Agency prohibited list. Nevertheless, in elite-level cycling, banned substance use is widespread. The present research adopted a psychological approach to examine how or whether perceived health risks influence elite-level cyclists' decisions to use banned substances. Sixteen semi-structured interviews were conducted with cyclists hoping to join a professional team (n=6), neo-professional cyclists (n=2), and former professional cyclists (n=8). Although an evolution was observed in the organization of doping and perceptions of doping over the last decade, the perceived health hazards did not influence, most of the time, decisions to use banned substances among the sample of cyclists. There was a systematization of exogenous substance use in the cycling environment and a trivialization of the side effects of the banned substances. Finally, younger cyclists were not concerned about the long-term health consequences of banned substances; they were more focused on the short-term performance-enhancing benefits. There is a need to implement more effective preventive programs to change athletes' attitudes toward doping and its health risks. © 2011 John Wiley & Sons A/S.
Persistent Identifierhttp://hdl.handle.net/10722/161382
ISSN
2015 Impact Factor: 3.025
2015 SCImago Journal Rankings: 1.192
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLentillonKaestner, Ven_US
dc.contributor.authorHagger, MSen_US
dc.contributor.authorHardcastle, Sen_US
dc.date.accessioned2012-08-24T08:31:01Z-
dc.date.available2012-08-24T08:31:01Z-
dc.date.issued2012en_US
dc.identifier.citationScandinavian Journal Of Medicine And Science In Sports, 2012, v. 22 n. 5, p. 596-606en_US
dc.identifier.issn0905-7188en_US
dc.identifier.urihttp://hdl.handle.net/10722/161382-
dc.description.abstractThe protection of the health of athletes is one of the three criteria taken into account when registering a substance in the World Anti-Doping Agency prohibited list. Nevertheless, in elite-level cycling, banned substance use is widespread. The present research adopted a psychological approach to examine how or whether perceived health risks influence elite-level cyclists' decisions to use banned substances. Sixteen semi-structured interviews were conducted with cyclists hoping to join a professional team (n=6), neo-professional cyclists (n=2), and former professional cyclists (n=8). Although an evolution was observed in the organization of doping and perceptions of doping over the last decade, the perceived health hazards did not influence, most of the time, decisions to use banned substances among the sample of cyclists. There was a systematization of exogenous substance use in the cycling environment and a trivialization of the side effects of the banned substances. Finally, younger cyclists were not concerned about the long-term health consequences of banned substances; they were more focused on the short-term performance-enhancing benefits. There is a need to implement more effective preventive programs to change athletes' attitudes toward doping and its health risks. © 2011 John Wiley & Sons A/S.en_US
dc.languageengen_US
dc.publisherBlackwell Munksgaard. The Journal's web site is located at http://www.blackwellpublishing.com/journals/SMSen_US
dc.relation.ispartofScandinavian Journal of Medicine and Science in Sportsen_US
dc.subjectAmateur Levelen_US
dc.subjectCyclingen_US
dc.subjectDoping Behaviorsen_US
dc.subjectHealth Risksen_US
dc.subjectPerformance-Enhancing Drugsen_US
dc.subjectProfessional Levelen_US
dc.subjectSporten_US
dc.titleHealth and doping in elite-level cyclingen_US
dc.typeArticleen_US
dc.identifier.emailHagger, MS:martin.hagger@nottingham.ac.uken_US
dc.identifier.authorityHagger, MS=rp01644en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1111/j.1600-0838.2010.01281.xen_US
dc.identifier.pmid21392123-
dc.identifier.scopuseid_2-s2.0-79960084421en_US
dc.identifier.isiWOS:000308715400008-
dc.publisher.placeDenmarken_US
dc.identifier.scopusauthoridLentillonKaestner, V=31967655000en_US
dc.identifier.scopusauthoridHagger, MS=55238094100en_US
dc.identifier.scopusauthoridHardcastle, S=7003333859en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats